Szablewski Vanessa, René Céline, Costes Valérie
Département de Biopathologie Cellulaire et Tissulaire des Tumeurs, CHU Montpellier, Hôpital Gui De Chauliac, 34275, Montpellier, France.
Département d'Immunologie, CHU Montpellier, Hôpital Saint Eloi, 34275, Montpellier, France.
Virchows Arch. 2015 Oct 22. doi: 10.1007/s00428-015-1862-0.
Patients with common variable immunodeficiency disorder (CVID) are subject to lymphoproliferative disorders and predisposed to lymphoma. Some patients may also develop liver lesions. The purpose of this study was to define clinical and histopathological features of patients with CVID presenting with liver lesions suspicious of lymphoma. Four CVID cases corresponding to these criteria were retrieved from our files. Liver biopsy specimens were subjected to morphologic, immunophenotypic and molecular analysis. All patients presented with hepatosplenomegaly and two furthermore with lymphadenopathy. The clinical working diagnosis in the four cases was lymphoma. All liver biopsies revealed nodular regenerative hyperplasia (NRH), associated with mild to marked sinusoid lymphocytic infiltrate consisting of "activated" cytotoxic T cells (CD8+, Tia1+, granzyme B+, TCRβF1+, CD56-). EBER was negative in all cases. T cell clonality was found in one of the two interpretable cases. All patients had an indolent course and clinical symptoms regressed with immunoglobulin replacement. This study suggests that indolent proliferation in the liver sinusoid of cytotoxic T cell associated with NRH is a specific liver lesion in the context of CVID. In CVID patients clinically suspected of lymphoma, pathologists should avoid a misdiagnosis of aggressive T cell lymphoma with a risk of over treatment.
普通可变免疫缺陷病(CVID)患者易患淋巴增殖性疾病且易患淋巴瘤。一些患者还可能出现肝脏病变。本研究的目的是明确表现出疑似淋巴瘤肝脏病变的CVID患者的临床和组织病理学特征。从我们的病例档案中检索出符合这些标准的4例CVID病例。对肝活检标本进行形态学、免疫表型和分子分析。所有患者均有肝脾肿大,另外2例有淋巴结病。这4例患者的临床初步诊断为淋巴瘤。所有肝活检均显示结节性再生性增生(NRH),伴有轻度至显著的窦状隙淋巴细胞浸润,由“活化”的细胞毒性T细胞(CD8 +、Tia1 +、颗粒酶B +、TCRβF1 +、CD56 -)组成。所有病例中EBER均为阴性。在2例可解释的病例中,1例发现T细胞克隆性。所有患者病程呈惰性,临床症状经免疫球蛋白替代治疗后消退。本研究表明,与NRH相关的细胞毒性T细胞在肝窦内的惰性增殖是CVID背景下一种特定的肝脏病变。在临床怀疑为淋巴瘤的CVID患者中,病理学家应避免误诊为侵袭性T细胞淋巴瘤,以免有过度治疗的风险。